ARIEL3: a phase 3, randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian cancer (OC).
Coleman, R Oza, A Lorusso, D Aghajanian, C Oaknin, A Dean, A Colombo, N Weberpals, J Clamp, Andrew R Scambia, G
Coleman, R
Oza, A
Lorusso, D
Aghajanian, C
Oaknin, A
Dean, A
Colombo, N
Weberpals, J
Clamp, Andrew R
Scambia, G
Citations
Altmetric:
Abstract
Description
Date
2018-08-01
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
ARIEL3: a phase 3, randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian cancer (OC). 2018, 24(15_Suppl): 30-31 Clin Cancer Res